Design and immunogenicity of SARS-CoV-2 DNA vaccine encoding RBD-PVXCP fusion protein
D. Dormeshkin, M. Katsin, M. Stegantseva, S. Golenchenko, M. Shapira, S. Dubovik, D. Lutskovich, A. Kavaleuski, A. Meleshko, Vaccines 11 (2023).

Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development
D. Dormeshkin, M. Shapira, A. Karputs, A. Kavaleuski, I. Kuzminski, E. Stepanova, A. Gilep, Applied Microbiology and Biotechnology 106 (2022) 5093–5103.